Astrazeneca Lp Drug Patent Portfolio

Astrazeneca Lp's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Astrazeneca Lp News

AstraZeneca plc's shares are under examination due to challenges in its oncology pipeline and delays in regulatory approvals.

26 Mar, 2026

AstraZeneca's Imfinzi Receives EU Approval for Gastric Cancer Treatment - TradingView

17 Mar, 2026

Alteogen on the Verge of Success in the US: Can It Take the Lead in the SC Formulation Competition?

03 Mar, 2026

AstraZeneca's legal victory puts a stop to a more affordable diabetes medication - | National News

16 Feb, 2026

See More